UNI-EN 17:Current report 18 re insiders transactions
Firma: SOPHARMA ADSpis treści:
1. REPORT
2. INFORMATION ABOUT THE ENTITY
3. SIGNATURE OF PERSONS REPRESENTING THE COMPANY
Spis załączników:
| POLISH FINANCIAL SUPERVISION AUTHORITY | |||||||||||
| | UNI - EN REPORT No | 17 | / | 2013 | | ||||||
| Date of issue: | 2013-02-04 | ||||||||||
| Short name of the issuer | |||||||||||
| SOPHARMA AD | |||||||||||
| Subject | |||||||||||
| Current report 18 re insiders transactions | |||||||||||
| Official market - legal basis | |||||||||||
| Art. 160 ust 4 Ustawy o obrocie - informacja o transakcjach osуb maj№cych dostкp do informacji poufnych | |||||||||||
| Unofficial market - legal basis | |||||||||||
| Contents of the report: | |||||||||||
| The Board of Directors of Sopharma AD (the “Company") announces that it was notified by Mr. Ognian Donev, Chairman of the Board of Directors that the company “Donev Investments Holding AD" related to him, executed the following transactions related to shares in the Company: Date and time of the settlement Operation Number of shares Unit price (BGN) 28.01.2013 Sale 500 2.332 28.01.2013 Sale 2000 2.31 28.01.2013 Sale 500 2.362 28.01.2013 Sale 450 2.375 28.01.2013 Sale 200 2.35 28.01.2013 Sale 300 2.355 28.01.2013 Sale 500 2.355 28.01.2013 Sale 1600 2.36 28.01.2013 Sale 1000 2.35 28.01.2013 Sale 5000 2.35 28.01.2013 Sale 3000 2.35 28.01.2013 Sale 2500 2.35 28.01.2013 Sale 200 2.353 28.01.2013 Sale 500 2.348 28.01.2013 Sale 500 2.375 28.01.2013 Sale 110 2.35 28.01.2013 Sale 90 2.35 28.01.2013 Sale 100 2.35 28.01.2013 Sale 115 2.35 28.01.2013 Sale 385 2.35 29.01.2013 Sale 600 2.353 30.01.2013 Sale 500 2.358 31.01.2013 Sale 500 2.37 31.01.2013 Sale 500 2.37 The transfer of the above-mentioned shares was executed on the Bulgarian Stock Exchange in Sofia (regulated market) by way of electronic trade. | |||||||||||
| Annexes | |||||||||||
| File | Description | ||||||||||
| Current report 18 re insiders transactions.doc Current report 18 re insiders transactions.doc | Current report 18 re insiders transactions | ||||||||||
| SOPHARMA AD | |||||||||||||
| (fullname of the issuer) | |||||||||||||
| SOPHARMA AD | Farmaceutyczny (far) | ||||||||||||
| (short name of the issuer) | (sector according to clasification of the WSE in Warsow) | ||||||||||||
| 1220 | Sofia | ||||||||||||
| (post code) | (city) | ||||||||||||
| IlienskoShosse | 16 | ||||||||||||
| (street) | (number) | ||||||||||||
| +359 2 813 42 00 | +359 2 936 02 86 | ||||||||||||
| (phone number) | (fax) | ||||||||||||
| (e-mail) | (web site) | ||||||||||||
| nd | |||||||||||||
| (NIP) | (REGON) | ||||||||||||
| SIGNATURE OF PERSONS REPRESENTING THE COMPANY | |||||
| Date | Name | Position / Function | Signature | ||
| 2013-02-04 | Ognian Donev | Executive Director | |||
Cena akcji Sopharma
Cena akcji Sopharma w momencie publikacji komunikatu to None PLN. Sprawdź ile kosztuje akcja Sopharma aktualnie.
W tej sekcji znajdziesz wszystkie komunikaty ESPI EBI Sopharma.
